BRIEF published on 08/01/2024 at 15:13, 1 month 19 days ago Black Diamond Networks Announces European Expansion Staffing Solutions Technology Life Sciences European Expansion Basel Office
BRIEF published on 08/01/2024 at 15:13, 1 month 19 days ago Black Diamond Networks annonce son expansion européenne Technologie Expansion Européenne Sciences De La Vie Solutions De Dotation Bureau De Bâle
PRESS RELEASE published on 08/01/2024 at 15:08, 1 month 19 days ago Black Diamond Networks Announces European Expansion Black Diamond Networks expands to Europe with new office in Basel, Switzerland, focusing on life sciences and technology sectors. VP Rob Berlan to lead the international operations Life Sciences Technology Europe Expansion Black Diamond Networks Basel Switzerland International Office
Published on 09/20/2024 at 15:00, 29 minutes ago DISCOVER FH Collaboration With Family Heart Foundation, UT Southwestern, and Partners
Published on 09/20/2024 at 14:30, 59 minutes ago Focus Universal Inc. Announces Listing Transfer to Nasdaq Capital Market
Published on 09/20/2024 at 14:00, 1 hour 29 minutes ago Scepter Files Form 10 with SEC Paving the Way for Strategic Growth
Published on 09/20/2024 at 14:00, 1 hour 29 minutes ago Tectonic Metals Announces Results Of 2024 Annual General Meeting
Published on 09/20/2024 at 13:00, 2 hours 29 minutes ago Aston Bay and American West Metals Thick High-Grade Copper in Deep Drilling at the Storm Project, Nunavut, Canada
Published on 09/20/2024 at 15:14, 14 minutes ago a sknet becomes part of Academic Software Resulting in a powerful combination of two leaders in digital education.
Published on 09/20/2024 at 14:58, 30 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Published on 09/20/2024 at 14:56, 33 minutes ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Published on 09/20/2024 at 08:45, 6 hours 44 minutes ago BAIKOWSKI : Rapport financier semestriel 2024
Published on 09/20/2024 at 08:00, 7 hours 29 minutes ago MEDESIS PHARMA : Résultats encourageants de la première phase de l’essai clinique de phase 2a pour le traitement de la maladie d’Alzheimer avec le NanoLIthium
